• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植物抗宿主病(GVHD)预防的最新进展

Recent advances in graft-versus-host disease (GVHD) prevention.

作者信息

Blazar B R, Korngold R, Vallera D A

机构信息

Department of Pediatrics, University of Minnesota Hospital and Clinics, Minneapolis 55455, USA.

出版信息

Immunol Rev. 1997 Jun;157:79-109. doi: 10.1111/j.1600-065x.1997.tb00976.x.

DOI:10.1111/j.1600-065x.1997.tb00976.x
PMID:9255624
Abstract

In the 1970s and 1980s, GVHD prevention approaches were limited in number. Recent advances in our understanding of the requirements for T-cell immune responses and for basic mechanism(s) involved in GVHD pathophysiology have led to exciting new strategies for GVHD prevention. This review focuses upon recent developments in GVHD prevention generated over the past 5 years. We have selected five different types of strategies to highlight including: 1) the in vivo targeting of GVHD-reactive T cells using either intact and F(ab')2 fragments of monoclonal antibodies directed against T-cell-surface determinants or immunotoxins which consist of antibodies linked to toxins, 2) a comparison of the in vivo immunosuppressive effects of FK506 and rapamycin on T-cell signaling, 3) the inhibition of T-cell activation through blockade of costimulatory or adhesogenic signals, 4) shifting the balance between acute GVHD-inducing T-helper-type 1 (Th1) T cells to anti-inflammatory T-helper-type 2 (Th2)-type T cells, and 5) the regulation of alloreactive T-cell activation by treatment with peptide analogs which affect either TCR/MHC, CD4/MHC class II, or CD8/MHC class I interactions. Collectively, these approaches are illustratrative of the progress made in extending our GVHD prevention armamentarium.

摘要

在20世纪70年代和80年代,移植物抗宿主病(GVHD)的预防方法数量有限。近年来,我们对T细胞免疫反应的需求以及GVHD病理生理学所涉及的基本机制的理解取得了进展,从而产生了令人兴奋的GVHD预防新策略。本综述聚焦于过去5年中GVHD预防方面的最新进展。我们选择了五种不同类型的策略进行重点介绍,包括:1)使用针对T细胞表面决定簇的单克隆抗体的完整片段和F(ab')2片段或由与毒素相连的抗体组成的免疫毒素在体内靶向GVHD反应性T细胞;2)比较FK506和雷帕霉素对T细胞信号传导的体内免疫抑制作用;3)通过阻断共刺激或黏附信号来抑制T细胞活化;4)将诱导急性GVHD的T辅助1型(Th1)T细胞与抗炎性T辅助2型(Th2)T细胞之间的平衡进行转变;5)用影响TCR/MHC、CD4/MHC II类或CD8/MHC I类相互作用的肽类似物处理来调节同种反应性T细胞活化。总体而言,这些方法说明了我们在扩展GVHD预防手段方面所取得的进展。

相似文献

1
Recent advances in graft-versus-host disease (GVHD) prevention.移植物抗宿主病(GVHD)预防的最新进展
Immunol Rev. 1997 Jun;157:79-109. doi: 10.1111/j.1600-065x.1997.tb00976.x.
2
Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.环孢素诱导的同基因移植物抗宿主病:通过用针对T淋巴细胞细胞表面决定簇和MHC II类抗原的单克隆抗体治疗预防自身攻击。
Clin Immunol Immunopathol. 1993 Dec;69(3):341-50. doi: 10.1006/clin.1993.1190.
3
Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.CTLA4Ig对小鼠移植物抗宿主病(GVHD)发展的不同影响:CTLA4Ig可预防急性和慢性GVHD的发展,但仅能逆转慢性GVHD。
J Immunol. 1996 Nov 1;157(9):4258-67.
4
Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.无丝裂原性抗CD3F(ab')2片段可抑制跨越主要组织相容性屏障诱导的致死性小鼠移植物抗宿主病。
J Immunol. 1993 Jan 1;150(1):265-77.
5
Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.通过白细胞介素-2治疗抑制移植物抗宿主病与扩增的移植物抗宿主反应性CD4+辅助细胞产生细胞因子的改变有关。
Transplantation. 1995 Sep 15;60(5):481-90. doi: 10.1097/00007890-199509000-00014.
6
Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies.急性移植物抗宿主病的免疫发病机制:对新型预防和治疗策略的启示
Ann Hematol. 2004 Sep;83(9):551-65. doi: 10.1007/s00277-004-0890-7. Epub 2004 Jun 15.
7
Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases.给予抗CD137配体单克隆抗体对CD8(+) T细胞反应的优先阻断导致对小鼠急性和慢性移植物抗宿主病发展的不同影响。
J Immunol. 2001 Nov 1;167(9):4981-6. doi: 10.4049/jimmunol.167.9.4981.
8
Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.抗CD3ε F(ab')2片段在移植物抗宿主病或对名义抗原的初次免疫反应期间可在体内抑制T细胞增殖。
J Immunol. 1997 Dec 15;159(12):5821-33.
9
In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.体内或体外抗CD3ε链单克隆抗体疗法预防小鼠主要组织相容性屏障致死性移植物抗宿主病
J Immunol. 1994 Apr 1;152(7):3665-74.
10
Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect.FK506对引发移植物抗宿主病及移植物抗白血病效应的供体T细胞功能的影响。
Transplantation. 2004 Feb 15;77(3):391-8. doi: 10.1097/01.TP.0000111759.48240.F5.

引用本文的文献

1
Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy.超越T细胞亚群:干性与适应性重新定义免疫及免疫疗法
Cell Mol Immunol. 2025 Jul 10. doi: 10.1038/s41423-025-01321-7.
2
GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.GRIM19通过下调STAT3和NF-AT的激活来调节Th17和Treg细胞平衡,从而改善急性移植物抗宿主病(GVHD)。
J Transl Med. 2016 Jul 8;14(1):206. doi: 10.1186/s12967-016-0963-0.
3
Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.
用于鉴定血液系统恶性肿瘤中T细胞识别的肿瘤抗原的策略,以改善异基因血液和骨髓移植后的移植物抗肿瘤反应。
Biol Blood Marrow Transplant. 2015 Jun;21(6):1000-7. doi: 10.1016/j.bbmt.2014.11.001. Epub 2014 Nov 20.
4
Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.药物抑制 PKCα 和 PKCθ 可预防小鼠移植物抗宿主病,同时保留移植物抗白血病活性。
Blood. 2013 Oct 3;122(14):2500-11. doi: 10.1182/blood-2012-12-471938. Epub 2013 Aug 1.
5
Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells.利用黏液瘤病毒进行病毒疗法可预防原发性人造血干细胞异种移植后致命的移植物抗宿主病。
PLoS One. 2012;7(8):e43298. doi: 10.1371/journal.pone.0043298. Epub 2012 Aug 14.
6
Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.C3 缺陷小鼠中的移植物抗宿主病减少与供体 Th1/Th17 分化减少有关。
Biol Blood Marrow Transplant. 2012 Aug;18(8):1174-81. doi: 10.1016/j.bbmt.2012.05.014. Epub 2012 Jun 1.
7
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism.低剂量自然杀伤 T 细胞通过 IL-4 依赖机制提供对急性移植物抗宿主病的保护。
Blood. 2011 Mar 17;117(11):3220-9. doi: 10.1182/blood-2010-08-303008. Epub 2011 Jan 21.
8
Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice.DNAX 辅助分子-1(DNAM-1)在小鼠急性移植物抗宿主病中的关键作用。
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18593-8. doi: 10.1073/pnas.1005582107. Epub 2010 Oct 11.
9
PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.PKCθ 对于同种异体反应和移植物抗宿主病是必需的,但对于小鼠针对白血病和感染的免疫反应则不是必需的。
J Clin Invest. 2009 Dec;119(12):3774-86. doi: 10.1172/JCI39692. Epub 2009 Nov 9.
10
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.洛伐他汀阻断 LFA-1 激活可预防小鼠骨髓移植中的移植物抗宿主病。
Biol Blood Marrow Transplant. 2009 Dec;15(12):1513-22. doi: 10.1016/j.bbmt.2009.08.013. Epub 2009 Oct 7.